E. Neil Moore – författare
Visar alla böcker från författaren E. Neil Moore. Handla med fri frakt och snabb leverans.
25 produkter
Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents
Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988
Av J. Morganroth, E. Neil Moore
Inbunden, 1989
2250 kr
Lägg i varukorg
The Symposium on New Drugs provides a forum for academic investigators, research and development personnel from the pharmaceutical industry and members of the Food and Drug Administration to discuss important clinical research issues. The Ninth Annual symposium on New Drugs addressed the problem of …
Use and Approval of Antihypertensive Agents and Surrogate Endpoints for the Approval of Drugs Affecting Antiarrhythmic Heart Failure and Hypolipidemia
Proceedings of the Tenth Annual Symposium on New Drugs & Devices, October 31 – November 1, 1989
Av J. Morganroth, E. Neil Moore
Inbunden, 1990
1686 kr
Lägg i varukorg
The Symposium on New Drugs provides for an annual forum for academic investigators, research and development personnel from the pharmaceutical and related health care industries, and members of the Food and Drug Administration to discuss important clinical research issues. The Tenth Annual …
Silent Myocardial Ischemia
Proceedings of the Symposium on New Drugs and Devices October 15–16, 1987, Philadelphia, Pennsylvania
Av J. Morganroth, E. Neil Moore
Inbunden, 1988
1686 kr
Lägg i varukorg
Although some investigators have questioned the importance and even the existence of silent myocardial ischemia, documentation presented at this two day symposium leaves little doubt about its existence and importance. It has been estimated that about 3 million of the estimated 4 million angina …
Sudden Cardiac Death and Congestive Heart Failure: Diagnosis and Treatment
Proceedings of the Symposium on New Drugs and Devices, held at Philadelphia, PA, October 26 and 27, 1982
Av J. Morganroth, E. Neil Moore
Inbunden, 1983
1686 kr
Lägg i varukorg
In Harch of 1980, we organized the first symposium on how to evaluate new antiarrhythmic agents in which the participants included members of the Cardio-Renal Division of the Food and Drug Administration, academic investigators from the United States and Abroad and directors and imple mentors of …
Interventions in the Acute Phase of Myocardial Infarction
Av J. Morganroth, E. Neil Moore
Inbunden, 1984
1126 kr
Lägg i varukorg
In the 1980's a primary focus for intense cardiovascular research is in the treatment of patients with acute myocardial infarction. Although the prevalence of this syndrome has been decreasing in the United States, still over 1.5 million patients develop myocardial infarction per year. There is …
Cardiac Arrhythmias: New Therapeutic Drugs and Devices
Proceedings of the Symposium on New Drugs and Devices, held at Philadelphia, PA October 4 and 5, 1984
Av J. Morganroth, E. Neil Moore
Inbunden, 1985
1686 kr
Lägg i varukorg
In summary, there are many animal models that are useful in selecting new antiarrhythmic drugs. The selection of which model is most idea depends upon precisely what question is being asked. The large number of experimental models used to evaluate antiarrhythmic compounds points out the inability …
Congestive Heart Failure
Proceedings of the Symposium on New Drugs and Devices October 30–31, 1986, Philadelphia, Pennsylvania
Av J. Morganroth, E. Neil Moore
Inbunden, 1987
2469 kr
Lägg i varukorg
About 2. 5 million individuals have congestive heart fai lure in the United States with over 400,000 new cases expected annually. Congestive heart failure also is one of the commonest causes for hospital admissions accounting for over 5 million hospital days per year. Despite the early recognition …
Use and Approval of Antihypertensive Agents and Surrogate Endpoints for the Approval of Drugs Affecting Antiarrhythmic Heart Failure and Hypolipidemia
Proceedings of the Tenth Annual Symposium on New Drugs & Devices, October 31 – November 1, 1989
Av J. Morganroth, E. Neil Moore
Häftad, 2011
1686 kr
Lägg i varukorg
The Symposium on New Drugs provides for an annual forum for academic investigators, research and development personnel from the pharmaceutical and related health care industries, and members of the Food and Drug Administration to discuss important clinical research issues. The Tenth Annual …
Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents
Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988
Av J. Morganroth, E. Neil Moore
Häftad, 2011
2245 kr
Lägg i varukorg
The Symposium on New Drugs provides a forum for academic investigators, research and development personnel from the pharmaceutical industry and members of the Food and Drug Administration to discuss important clinical research issues. The Ninth Annual symposium on New Drugs addressed the problem of …
Silent Myocardial Ischemia
Proceedings of the Symposium on New Drugs and Devices October 15–16, 1987, Philadelphia, Pennsylvania
Av J. Morganroth, E. Neil Moore
Häftad, 2012
1686 kr
Lägg i varukorg
Although some investigators have questioned the importance and even the existence of silent myocardial ischemia, documentation presented at this two day symposium leaves little doubt about its existence and importance. It has been estimated that about 3 million of the estimated 4 million angina …
Congestive Heart Failure
Proceedings of the Symposium on New Drugs and Devices October 30–31, 1986, Philadelphia, Pennsylvania
Av J. Morganroth, E. Neil Moore
Häftad, 2011
2469 kr
Lägg i varukorg
About 2. 5 million individuals have congestive heart fai lure in the United States with over 400,000 new cases expected annually. Congestive heart failure also is one of the commonest causes for hospital admissions accounting for over 5 million hospital days per year. Despite the early recognition …
Cardiac Arrhythmias: New Therapeutic Drugs and Devices
Proceedings of the Symposium on New Drugs and Devices, held at Philadelphia, PA October 4 and 5, 1984
Av J. Morganroth, E. Neil Moore
Häftad, 2011
1686 kr
Lägg i varukorg
In summary, there are many animal models that are useful in selecting new antiarrhythmic drugs. The selection of which model is most idea depends upon precisely what question is being asked. The large number of experimental models used to evaluate antiarrhythmic compounds points out the inability …
Use and Approval of Antihypertensive Agents and Surrogate Endpoints for the Approval of Drugs Affecting Antiarrhythmic Heart Failure and Hypolipidemia
Proceedings of the Tenth Annual Symposium on New Drugs & Devices, October 31 – November 1, 1989
Av E. Neil Moore, J. Morganroth
E-bok, 2012
2174 kr
Lägg i varukorg
The Symposium on New Drugs provides for an annual forum for academic investigators, research and development personnel from the pharmaceutical and related health care industries, and members of the Food and Drug Administration to discuss important clinical research issues. The Tenth Annual …
Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents
Proceedings of the Ninth Annual Symposium on New Drugs & Devices, October 27 & 28, 1988
Av E. Neil Moore, J. Morganroth
E-bok, 2012
3013 kr
Lägg i varukorg
The Symposium on New Drugs provides a forum for academic investigators, research and development personnel from the pharmaceutical industry and members of the Food and Drug Administration to discuss important clinical research issues. The Ninth Annual symposium on New Drugs addressed the problem of …
Silent Myocardial Ischemia
Proceedings of the Symposium on New Drugs and Devices October 15–16, 1987, Philadelphia, Pennsylvania
Av E. Neil Moore, J. Morganroth
E-bok, 2012
2174 kr
Lägg i varukorg
Although some investigators have questioned the importance and even the existence of silent myocardial ischemia, documentation presented at this two day symposium leaves little doubt about its existence and importance. It has been estimated that about 3 million of the estimated 4 million angina …
Congestive Heart Failure
Proceedings of the Symposium on New Drugs and Devices October 30–31, 1986, Philadelphia, Pennsylvania
Av E. Neil Moore, J. Morganroth
E-bok, 2012
3348 kr
Lägg i varukorg
About 2. 5 million individuals have congestive heart fai lure in the United States with over 400,000 new cases expected annually. Congestive heart failure also is one of the commonest causes for hospital admissions accounting for over 5 million hospital days per year. Despite the early recognition …
Cardiac Arrhythmias: New Therapeutic Drugs and Devices
Proceedings of the Symposium on New Drugs and Devices, held at Philadelphia, PA October 4 and 5, 1984
Av E. Neil Moore, J. Morganroth
E-bok, 2012
2174 kr
Lägg i varukorg
In summary, there are many animal models that are useful in selecting new antiarrhythmic drugs. The selection of which model is most idea depends upon precisely what question is being asked. The large number of experimental models used to evaluate antiarrhythmic compounds points out the inability …
Interventions in the Acute Phase of Myocardial Infarction
Av E. Neil Moore, J. Morganroth
E-bok, 2012
1459 kr
Lägg i varukorg
In the 1980''s a primary focus for intense cardiovascular research is in the treatment of patients with acute myocardial infarction. Although the prevalence of this syndrome has been decreasing in the United States, still over 1.5 million patients develop myocardial infarction per year. There is …
Interventions in the Acute Phase of Myocardial Infarction
Av J. Morganroth, E. Neil Moore
Häftad, 2011
1126 kr
Lägg i varukorg
In the 1980's a primary focus for intense cardiovascular research is in the treatment of patients with acute myocardial infarction. Although the prevalence of this syndrome has been decreasing in the United States, still over 1.5 million patients develop myocardial infarction per year. There is …
Sudden Cardiac Death and Congestive Heart Failure: Diagnosis and Treatment
Proceedings of the Symposium on New Drugs and Devices, held at Philadelphia, PA, October 26 and 27, 1982
Av E. Neil Moore, J. Morganroth
E-bok, 2012
2174 kr
Lägg i varukorg
In Harch of 1980, we organized the first symposium on how to evaluate new antiarrhythmic agents in which the participants included members of the Cardio-Renal Division of the Food and Drug Administration, academic investigators from the United States and Abroad and directors and imple mentors of …
Sudden Cardiac Death and Congestive Heart Failure: Diagnosis and Treatment
Proceedings of the Symposium on New Drugs and Devices, held at Philadelphia, PA, October 26 and 27, 1982
Av J. Morganroth, E. Neil Moore
Häftad, 2011
1686 kr
Lägg i varukorg
In Harch of 1980, we organized the first symposium on how to evaluate new antiarrhythmic agents in which the participants included members of the Cardio-Renal Division of the Food and Drug Administration, academic investigators from the United States and Abroad and directors and imple mentors of …
Evaluation of Beat Blocker and Calcium Antagonist Drugs
Av E. Neil Moore, J. Morganroth
E-bok, 2012
755 kr
Lägg i varukorg
With the beginning of the 1980''s it was becoming increasingly evident that the lack of approval of new cardiovascular agents for use by clinicians in the United States for the treatment of cardiovascular disorders was becoming a problem. Patients requiring medical therapy for hypertension, angina …
Evaluation of Beat Blocker and Calcium Antagonist Drugs
Av J. Morganroth, E. Neil Moore
Häftad, 2011
568 kr
Lägg i varukorg
With the beginning of the 1980's it was becoming increasingly evident that the lack of approval of new cardiovascular agents for use by clinicians in the United States for the treatment of cardiovascular disorders was becoming a problem. Patients requiring medical therapy for hypertension, angina …
Evaluation of New Antiarrhythmic Drugs
Proceedings of the Symposium on How to Evaluate a New Antiarrhythmic Drug: The Evaluation of New Antiarrhythmic Agents for the Treatment of Ventricular Arrhythmias, held at Philadelphia, Pennsylvania, October 8–9, 1980
Av E.L. Michelson, L.S. Dreifus m. fl.
E-bok, 2012
755 kr
Lägg i varukorg
Thus, there are now several chronic canine myocardial infarction ventricular tachyarrhythmia models which are available for the evaluation of new antiarrhythmic drugs (Table I). The available models fulfill many, but not all of the requirements for an ideal chronic arrhythmia model (Table 11). The …
Evaluation of New Antiarrhythmic Drugs
Proceedings of the Symposium on How to Evaluate a New Antiarrhythmic Drug: The Evaluation of New Antiarrhythmic Agents for the Treatment of Ventricular Arrhythmias, held at Philadelphia, Pennsylvania, October 8–9, 1980
Av J. Morganroth, E. Neil Moore m. fl.
Häftad, 2011
568 kr
Lägg i varukorg
Thus, there are now several chronic canine myocardial infarction ventricular tachyarrhythmia models which are available for the evaluation of new antiarrhythmic drugs (Table I). The available models fulfill many, but not all of the requirements for an ideal chronic arrhythmia model (Table 11). The …
